| scholarly article | Q13442814 |
| P50 | author | Oscar Cuevas | Q43163589 |
| Jesús Oteo | Q56990531 | ||
| Francisco Jose De Abajo Iglesias | Q64861858 | ||
| María Pérez-Vázquez | Q73772088 | ||
| Silvia García-Cobos | Q79731088 | ||
| P2093 | author name string | José Campos | |
| Edurne Lázaro | |||
| Spanish Members of EARSS | |||
| P2860 | cites work | Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data | Q31117937 |
| Outpatient antibiotic use in Europe and association with resistance: a cross-national database study | Q34393751 | ||
| Antimicrobial-resistant invasive Escherichia coli, Spain | Q35872947 | ||
| Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period | Q39671146 | ||
| Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection | Q43716737 | ||
| Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome | Q57543815 | ||
| Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998 | Q73560650 | ||
| [Trends in antibiotic consumption in Spain, 1985-2000] | Q74117400 | ||
| P433 | issue | 8 | |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 1259-1262 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain | |
| P478 | volume | 14 |
| Q47284987 | Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge. |
| Q35569208 | Antimicrobial resistance surveillance systems: Are potential biases taken into account? |
| Q46096643 | Appendicitis: is surgery the best option? |
| Q60937645 | Bibliometric Analysis of Global Research on Clavulanic Acid |
| Q43293884 | CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. |
| Q92081380 | Clinical Trajectories and Causes of Death in Septic Patients with a Low APACHE II Score |
| Q37026587 | Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina. |
| Q36971214 | Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli. |
| Q33798430 | Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates |
| Q37324603 | Novel approaches to discovery of antibacterial agents |
| Q53080242 | Pathogenic multiple antimicrobial resistant Escherichia coli serotypes in recreational waters of Mumbai, India: a potential public health risk. |
| Q41299425 | Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes |
| Q36086480 | Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli |
| Q91827583 | Terminalia chebula Retz. Fruit Extracts Inhibit Bacterial Triggers of Some Autoimmune Diseases and Potentiate the Activity of Tetracycline |
| Q42656074 | The current management of acute uncomplicated appendicitis: should there be a change in paradigm? A systematic review of the literatures and analysis of treatment performance |
| Q83296872 | The use of amoxicillin and clavulanic acid and quinolones as first choice antibiotics in uncomplicated urinary tract infections in Spain should be reviewed |
Search more.